Prot #PSSc-001: An Open-Label, Randomized, Phase 2 Study of the Safety and Tolerability of Pirfenidone when Administered to Patients with Systemic Sclerosis−Related Interstitial Lung Disease; The LOTUSS Trial: An Open-Label, RandOmized, Phase 2 STUdy of t

Project: Research project

Project Details

StatusFinished
Effective start/end date9/5/13 → 9/5/16

Funding

  • InterMune, Inc. (Prot #PSSc-001)